| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |